![[약업신문]Celltrion abandons clinical trials for COVID-19 prophylactic antibody treatment](http://www.yakup.com/data/editor/news/202102/h2novUG8VoA3AfuWJiVLVpg16dc4x.png "[약업신문]Celltrion abandons clinical trials for COVID-19 prophylactic antibody treatment")
Withdrawal in less than a month after selecting a government support project… Demand for systematic support measures
It was found that Celltrion had given up clinical trials for COVID-19 prophylactic antibody treatment, which was decided to proceed with government support.
According to the’Corona 19 treatment and vaccine new drug development project, abandonment of the 2nd selection task agreement in 2020′ submitted by the Ministry of Health and Welfare by Congressman Jeon Bong-min (Health and Welfare Committee, Suyeong-gu, Busan) It was found that the clinical trial of the anti-antibody therapy was abandoned.
—
The government provided a total of 31.7 billion won for the development of Celltrion’s antibody treatment through two occasions in August and November last year, and the antibody treatment, which was the primary task, was granted conditional approval from the Ministry of Food and Drug Safety on February 5th. I started using it.-
On the other hand, it was confirmed that the development of a preventive antibody treatment, which was the second selection task, was submitted to the government’s cross-ministerial new drug development project group in mid-December, less than a month after the project was selected.
The reason for giving up by Celltrion was found to be due to difficulties in recruiting clinical trial participants due to vaccine development and national blockade by global pharmaceutical companies.
On the other hand, two treatments under development with the government’s clinical support are Green Cross and Daewoong Pharmaceutical. The completion of phase 2 clinical trials for emergency approval is planned for August and September this year, respectively.
Regarding this, Congressman Bong-min Jeon said, “The government has invested hundreds of billions of dollars to develop a domestic treatment for Corona 19, but the treatment for severely ill patients, which is urgently developed, has not been developed.” “The government may have additional corona 19 re-proliferation In preparation for this, a more systematic support plan should be prepared.”
– .
